PL1-SN-27 - Acute Kidney Injury to Evaluate Amustaline/Glutathione Pathogen Reduced Red Cells in Cardiac Surgery: Outcomes of the ReCePI Phase III Clinical Trial
PL2-SN-27 - ADAMTS13-Chimeric Auto-Antigen Receptor (CAAR) T cells To Target Autoreactive B cells As A Treatment For Immune-mediated Thrombotic Thrombocytopenic Purpura
OA3-AM24-SN-12 - Yields in Reiterated Homage to Landsteiner’s Law: Is Binding Blood Banks to ABO Reverse Typing Necessary in Donors with an Established Historical ABO Group? The ABO Reverse Typing (ABORT-Donor)
AM24-SN-17-L - Sickle Cell Disease: Inching towards Transfusion Independence. Exploring the Journey from Chronic Transfusions to the Novel Biotherapeutics
Crisis in the Rural Hospital Without Access to Blood Transfusion: Innovative Strategies to Address Global Blood Deserts and the Blood D.E.S.E.R.T. Coalition
AM24-SN-24-L - Crisis in the Rural Hospital Without Access to Blood Transfusion: Innovative Strategies to Address Global Blood Deserts and the Blood D.E.S.E.R.T. Coalition
OA1-AM24-SN-23 - Clinical Evaluation of Leukoreduced Red Blood Cells After Automated Separation of Whole Blood by the Reveos™ System and Storage for 42 Days